Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank

Nature Genetics

Volumn 49, Issue 9, 2017, Pages 1311-1318

  Cortes, Adrian ^a,b   Dendrou, Calliope A ^a,b,c   Motyer, Allan ^d   Jostins, Luke ^a   Vukcevic, Damjan ^d,e   Dilthey, Alexander ^a,f   Donnelly, Peter ^a,g   Leslie, Stephen ^d,e   Fugger, Lars ^b,c,h   McVean, Gil ^a,i  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; HLA ANTIGEN;

ARTICLE; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BAYES THEOREM; BIOBANK; DIAGNOSTIC ACCURACY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEALTH CARE; HEREDITY; HLA SYSTEM; HUMAN; PHENOTYPIC VARIATION; PHYLOGENETIC TREE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; ADULT; AGED; ALLELE; CLASSIFICATION; CLUSTER ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HEALTH CARE DELIVERY; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICAL INFORMATION SYSTEM; MIDDLE AGED; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ALLELES; BAYES THEOREM; CLUSTER ANALYSIS; DELIVERY OF HEALTH CARE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEALTH INFORMATION SYSTEMS; HLA ANTIGENS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; UNITED KINGDOM;

EID: 85028691452     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3926     Document Type: Article

References (55)

1. Cohen, J.C., Boerwinkle, E., Mosley, T.H. Jr. & Hobbs, H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264-1272 (2006).
2. Mallal, S. et al. HLA-B 5701 screening for hypersensitivity to abacavir. N. Engl. J. Med. 358, 568-579 (2008).
3. Manolio, T.A. Bringing genome-wide association findings into clinical use. Nat. Rev. Genet. 14, 549-558 (2013).
4. Nelson, M.R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856-860 (2015).
5. Sanseau, P. et al. Use of genome-wide association studies for drug repositioning. Nat. Biotechnol. 30, 317-320 (2012).
6. Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
7. Thompson, S.G. & Willeit, P. UK Biobank comes of age. Lancet 386, 509-510 (2015).
8. Jonsson, T. et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99 (2012).
9. Denny, J.C. et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31, 1102-1110 (2013).
10. Karnes, J.H. et al. Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants. Sci. Transl. Med. 9, eaai8708 (2017).
11. Bush, W.S., Oetjens, M.T. & Crawford, D.C. Unravelling the human genome-phenome relationship using phenome-wide association studies. Nat. Rev. Genet. 17, 129-145 (2016).
12. Chan, K.S., Fowles, J.B. & Weiner, J.P. Electronic health records and the reliability and validity of quality measures: a review of the literature. Med. Care Res. Rev. 67, 503-527 (2010).
13. Denny, J.C., Bastarache, L. & Roden, D.M. Phenome-wide association studies as a tool to advance precision medicine. Annu. Rev. Genomics Hum. Genet. 17, 353-373 (2016).
14. Hersh, W.R. et al. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med. Care 51 (Suppl. 3), S30-S37 (2013).
15. Hripcsak, G. & Albers, D.J. Next-generation phenotyping of electronic health records. J. Am. Med. Inform. Assoc. 20, 117-121 (2013).
16. Song, Y. et al. Regional variations in diagnostic practices. N. Engl. J. Med. 363, 45-53 (2010).
17. International Genetics of Ankylosing Spondylitis Consortium. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nat. Genet. 45, 730-738 (2013).
18. Colmegna, I., Cuchacovich, R. & Espinoza, L.R. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin. Microbiol. Rev. 17, 348-369 (2004).
19. Eastmond, C.J. & Woodrow, J.C. The HLA system and the arthropathies associated with psoriasis. Ann. Rheum. Dis. 36, 112-120 (1977).
20. Martin, T.M. & Rosenbaum, J.T. An update on the genetics of HLA B27-associated acute anterior uveitis. Ocul. Immunol. Inflamm. 19, 108-114 (2011).
21. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289-300 (1995).
22. Takagi, I., Eliyas, J.K. & Stadlan, N. Cervical spondylosis: an update on pathophysiology, clinical manifestation, and management strategies. Dis. Mon. 57, 583-591 (2011).
23. Gritz, D.C. & Wong, I.G. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111, 491-500, discussion 500 (2004).
24. Okada, Y. et al. Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes. Am. J. Hum. Genet. 95, 162-172 (2014).
25. Tsoi, L.C. et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341-1348 (2012).
26. Gutierrez-Achury, J. et al. Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease. Nat. Genet. 47, 577-578 (2015).
27. Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44, 291-296 (2012).
28. Hu, X. et al. Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat. Genet. 47, 898-905 (2015).
29. Moutsianas, L. et al. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat. Genet. 47, 1107-1113 (2015).
30. Goyette, P. et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1 01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat. Genet. 47, 172-179 (2015).
31. Mart'nez-Taboda, V.M. et al. HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis. Semin. Arthritis Rheum. 34, 454-464 (2004).
32. Haworth, S. et al. Polymyalgia rheumatica is associated with both HLA-DRB1 0401 and DRB1 0404. Br. J. Rheumatol. 35, 632-635 (1996).
33. Cleynen, I. et al. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet 387, 156-167 (2016).
34. Denny, J.C. et al. Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome-and phenome-wide studies. Am. J. Hum. Genet. 89, 529-542 (2011).
35. Eriksson, N. et al. Novel associations for hypothyroidism include known autoimmune risk loci. PLoS One 7, e34442 (2012).
36. Mosley, J.D. et al. Identifying genetically driven clinical phenotypes using linear mixed models. Nat. Commun. 7, 11433 (2016).
37. Parkes, M., Cortes, A., van Heel, D.A. & Brown, M.A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661-673 (2013).
38. Chen, G.B. et al. Estimation and partitioning of (co)heritability of inflammatory bowel disease from GWAS and Immunochip data. Hum. Mol. Genet. 23, 4710-4720 (2014).
39. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
40. Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193-1201 (2011).
41. Cortes, A. et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat. Commun. 6, 7146 (2015).
42. Tsokos, G.C. Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110-2121 (2011).
43. de Lusignan, S. et al. A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. Diabet. Med. 27, 203-209 (2010).
44. Nogueira, T.C. et al. GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim. PLoS Genet. 9, e1003532 (2013).
45. Ostergaard, J.A., Laugesen, E. & Leslie, R.D. Should there be concern about autoimmune diabetes in adults? Current evidence and controversies. Curr. Diab. Rep. 16, 82 (2016).
46. Cervin, C. et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 57, 1433-1437 (2008).
47. Shields, B.M. et al. Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. BMJ Open 5, e009088 (2015).
48. Jensen, A.B. et al. Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients. Nat. Commun. 5, 4022 (2014).
49. Wain, L.V. et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir. Med. 3, 769-781 (2015).
50. Dilthey, A. et al. Multi-population classical HLA type imputation. PLOS Comput. Biol. 9, e1002877 (2013).
51. Motyer, A. et al. Practical use of methods for imputation of HLA alleles from SNP genotype data. Preprint at. bioRxiv http://dx.doi.org/10.1101/091009 (2016).
52. International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353-1360 (2013).
53. Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381 (2014).
54. Bentham, J. et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457-1464 (2015).
55. Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381-386 (2015).